Wilfredo Antonio Rivera-Martínez

7PUBLICATIONS
24CO-AUTHORS
PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Behavioural epidemiologyMolecular medicinePharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 28, 2026
Current Insights into Pasireotide Therapy for Uncontrolled Acromegaly: Biochemical Response, Tumor Reduction, and Glycemic Safety in a Real-World Latin American Cohort.

|Apr 01, 2026
Clinical characteristics, diagnosis, and treatment of Cushing's syndrome: analysis of a multicenter registry in Antioquia, Colombia.

Wilfredo Antonio Rivera-Martínez, María Johana Ramírez Castaño, Stefanía Cruz Calderón

|Sep 27, 2025
Factors related to reversal of prediabetes in patients from a cardiovascular risk program during 2019 - 2023.

Wilfredo Antonio Rivera-Martínez, Aura María Salazar-Solarte, Diana Marcela Sánchez-Machado

|Sep 22, 2025
Biochemical and Structural Response to Lenvatinib in Metastatic Parathyroid Carcinoma: Case Report.

Wilfredo A Rivera, María J Ramírez, Alejandro Román

|Dec 16, 2024
Author's Reply to Peronard and Mayntz: "SGLT2 Inhibitors, and How They Work Beyond the Glucosuric Effect".

David Aristizábal-Colorado, Martín Ocampo-Posada, Wilfredo Antonio Rivera-Martínez

|Aug 23, 2024
SGLT2 Inhibitors and How They Work Beyond the Glucosuric Effect. State of the Art.

David Aristizábal-Colorado, Martín Ocampo-Posada, Wilfredo Antonio Rivera-Martínez

Pageof 2

Frequent Collaborators

3 joint publications

Alin Abreu-Lomba

2 joint publications

Alejandro Román-González

2 joint publications

Aura María Salazar-Solarte

2 joint publications

David Aristizábal-Colorado